Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment.

British Journal of Cancer
W R MillerPhilippa T K Saunders

Abstract

In order to elucidate the relative importance of oestrogen receptor (ER)alpha, ERbeta and an ERbeta variant (ERbeta2/betacx) in the response of breast cancers to tamoxifen, tumour levels of each receptor were assessed in 36 patients before and after 3 months of neoadjuvant treatment with tamoxifen (20 mg daily). All patients were postmenopausal women presenting with large ERalpha-positive breast cancers. Clinical response to treatment was assessed by tumour volume changes as determined from sequential ultrasounds and pathological response by comparison of the tumour morphology before and after treatment. Of 33 cases, 23 (70%) were classified as having a clinical response and 16 (48%) as having a response pathologically. All tumours stained positively for ERalpha and ERbeta and 15 out of 33 (45%) for ERbeta2/betacx. There were no significant differences in quantitative expression of any receptor between tumours that subsequently responded and that did not, whether response was assessed clinically or pathologically. Tamoxifen treatment was associated with a decrease in ERalpha, but an increase was the most frequent change (17 out of 33) in ERbeta, and no consistent change was evident in staining of the ERbeta2/betacx variant. In ...Continue Reading

References

Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Jun 24, 1998·Biochemical and Biophysical Research Communications·J T MooreT M Willson
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z WeihuaJ A Gustafsson
Feb 13, 2001·Biochemical and Biophysical Research Communications·S InoueY Ouchi
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y OmotoH Iwase
Mar 1, 2002·British Journal of Cancer·P T K SaundersW R Miller
Dec 3, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shigehira SajiMasakazu Toi
Dec 13, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Indra PoolaAiyi Liu
Jan 10, 2003·The Journal of Clinical Endocrinology and Metabolism·Terri L GaskellPhilippa T K Saunders
Feb 13, 2003·Journal of Molecular Endocrinology·B PengL C Murphy
Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anders StrömJan-Ake Gustafsson
Feb 20, 2004·Journal of Mammary Gland Biology and Neoplasia·M WarnerJ A Gustafsson
Mar 9, 2004·The Lancet Oncology·Valerie SpeirsAndrew M Hanby
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlo PalmieriR Charles Coombes
Jun 3, 2004·Journal of Molecular Endocrinology·Jayne E SierensPhilippa T K Saunders
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Majida Esslimani-SahlaHenri Rochefort
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten A HoppSuzanne A W Fuqua

❮ Previous
Next ❯

Citations

Dec 11, 2013·International Journal of Breast Cancer·Gerald M Higa, Ryan G Fell
Mar 12, 2011·Breast Cancer Research : BCR·Xianglin WuJohn R Hawse
Jul 3, 2013·Journal of Cancer Research and Clinical Oncology·Nuiki Iota ChantziMuichael N Alexis
Jan 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Bo HuangJan-Åke Gustafsson
Aug 2, 2014·Cancer Biology & Therapy·Hyunki KimKurt R Zinn
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naoko HonmaGoi Sakamoto
Mar 28, 2013·Endocrine-related Cancer·Etienne Leygue, Leigh C Murphy
Jan 10, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Naoko HonmaGoi Sakamoto
May 1, 2011·Expert Review of Endocrinology & Metabolism·Etienne Leygue, Leigh Murphy
Nov 19, 2011·Journal of Cellular Biochemistry·Xianglin WuJohn R Hawse
Jun 11, 2020·Cancers·Assunta SellittoFrancesca Rizzo
Jun 7, 2017·Journal of Experimental & Clinical Cancer Research : CR·Wei SongXiaoxiang Guan
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Abeer M ShaabanValerie Speirs
Nov 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karin ElebroHelena Jernström
Feb 18, 2012·Pathology, Research and Practice·Kemal Kürşat Bozkurt, Nilgün Kapucuoğlu

❮ Previous
Next ❯

Datasets Mentioned

BETA
AB006590
MCA1974S
AB006589

Methods Mentioned

BETA
biopsies
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.